The Cavalier Daily
Serving the University Community Since 1890

Shetal Patel


Magnets may prove useful in treatment

Imagine living every day of your life in pain, not knowing what causes it or how to treat it. Thousands of Americans suffering from a condition called fibromyalgia live with this feeling, but University researchers may have found a way to reduce these patients' pain using magnetic sleep pads. The Journal of Alternative and Complementary Medicine published a study last month based on University research showing that a specific type of magnetic sleep pad decreased the intensity of pain in fibromyalgia patients. Fibromyalgia is a syndrome, or collection of symptoms, that is "characterized by widespread pain, fatigue, fitful or unrestful sleep, anxiety and other systemic kinds of symptoms," said Nursing Prof.

Jet lag linked to eating

Second-year graduate student Carmen Yip traveled to Hong Kong over winter break and, like many travelers, suffered from jet lag.

New mouse model uncovers mysteries behind Crohn's disease

Accidentally-bred mice may hold the cure for a debilitating intestinal disease. The mice, originally bred by a group of Japanese scientists to study the aging process, developed lower intestinal problems and now are key players in the study of Crohn's disease, which is the inflammation of the lower intestine. After scientists realized the mice were no good for their study, they shipped them all the way to Charlottesville, where University researchers are studying the disease. The University research got a jump start recently when the National Institute of Diabetes and Digestive and Kidney Diseases gave a $5.1 million grant over five years to fund further study of Crohn's disease. "If this mouse model truly represents human disease, this research will lead to a mechanistic understanding of Crohn's disease and help in the development of new therapeutic strategies," said Biomedical Engineering Prof.

New antibiotics may be unable to stave off bacterial attack

The proliferation of antibiotic-resistant strains of bacteria could nullify the effects of antibiotics, the miracle drugs of yesterday. Last week, the Food and Drug Administration approved Zyvox, an antibacterial drug that is part of a first new class of antibiotics to be developed in 35 years.

Study examines near-death episodes

"I relinquished my will and identification with personality and individuality, setting aside my sense of self," said Linda Stewart of Hamden, Connecticut, in an e-mail interview with The Cavalier Daily. Describing her near-death experience, Stewart said, "I felt a strange detachment from my physical body and the life I had created." Blurring the boundaries between science and religion, reality and dreams, the existence of near-death experiences is controversial.

More articles »